Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.98 is 29% above its 5-year average of -2.79, around the middle of its 5-year range (-5.80–0.19).
45.75% above its 12-month average of -3.65.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.10.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-02T19:05:52.185Z. Historical observations retain their original dates. Historical series through 2022-02-25.
EARNINGS PER SHARE (EPS)
-1.98
EARNINGS PER SHARE (EPS) AVG TTM
-3.65
EARNINGS PER SHARE (EPS) AVG 3Y
-4.15
EARNINGS PER SHARE (EPS) AVG 5Y
-2.79
EARNINGS PER SHARE (EPS) AVG 10Y
-1.53
EARNINGS PER SHARE (EPS) AVG 15Y
-0.04
EARNINGS PER SHARE (EPS) AVG 20Y
-0.11
CURRENT VS TTM AVG
+45.75%
CURRENT VS 3Y AVG
+52.29%
CURRENT VS 5Y AVG
+29.12%
CURRENT VS 10Y AVG
-29.22%
CURRENT VS 15Y AVG
-4395.74%
CURRENT VS 20Y AVG
-1706.28%
NeoGenomics, Inc.
Market Cap
$470.35M
Earnings Per Share (EPS)
-1.98
TTM Avg
-3.65
3Y Avg
-4.15
5Y Avg
-2.79
Market Cap
$389.98M
Earnings Per Share (EPS)
-1.71
TTM Avg
-1.36
3Y Avg
-1.12
5Y Avg
-1.12
Market Cap
$41.24M
Earnings Per Share (EPS)
-0.64
TTM Avg
-0.89
3Y Avg
-1.15
5Y Avg
-1.02
Market Cap
$1.01B
Earnings Per Share (EPS)
-0.99
TTM Avg
-3.50
3Y Avg
-23.24
5Y Avg
-16.84
Market Cap
$1.71B
Earnings Per Share (EPS)
-3.36
TTM Avg
-4.53
3Y Avg
-5.16
5Y Avg
-4.47
Market Cap
$1.74B
Earnings Per Share (EPS)
-2.74
TTM Avg
-3.74
3Y Avg
-3.13
5Y Avg
-1.84
Market Cap
$2.13B
Earnings Per Share (EPS)
-1.04
TTM Avg
-1.56
3Y Avg
-1.52
5Y Avg
-1.27
Market Cap
$2.49B
Earnings Per Share (EPS)
-0.86
TTM Avg
-2.70
3Y Avg
-2.81
5Y Avg
-3.40
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeoGenomics, Inc. (NEO) | $470.35M | -1.98 | -3.65 | -4.15 | -2.79 |
| NRC Health (NRC)vs › | $459.30M | 0.25 | 0.79 | 1.03 | 1.18 |
| Shoulder Innovations, Inc. (SI)vs › | $389.98M | -1.71 | -1.36 | -1.12 | -1.12 |
| PDS Biotechnology Corporation (PDSB)vs › | $41.24M | -0.64 | -0.89 | -1.15 | -1.02 |
| Teladoc Health, Inc. (TDOC)vs › | $1.01B | -0.99 | -3.50 | -23.24 | -16.84 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | -3.36 | -4.53 | -5.16 | -4.47 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | -2.74 | -3.74 | -3.13 | -1.84 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.13B | -1.04 | -1.56 | -1.52 | -1.27 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.49B | -0.86 | -2.70 | -2.81 | -3.40 |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 3.86 | 3.33 | 1.17 | 0.32 |
Trailing EPS (TTM)
$-1.98
Forward EPS (Est.)
$0.18
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -4.20 |
| 2024-12-31 | -3.10 |
| 2023-12-31 | -3.50 |
| 2022-12-31 | -5.80 |
| 2021-12-31 | -0.35 |
| 2020-12-31 | 0.19 |
| 2019-12-31 | 0.40 |
| 2018-12-31 | 0.14 |
| 2017-12-31 | -0.03 |
| 2016-12-31 | -0.40 |
| 2015-12-31 | -0.21 |
| 2014-12-31 | 0.10 |
| 2013-12-31 | 0.20 |
| 2012-12-31 | 0.01 |
| 2011-12-31 | -0.14 |
| 2010-12-31 | -0.44 |
| 2009-12-31 | -0.32 |
| 2008-12-31 | -0.22 |
| 2007-12-31 | -0.55 |
| 2006-12-31 | -0.03 |
| 2005-12-31 | -0.22 |
| 2004-12-31 | -0.20 |
| 2003-12-31 | -0.19 |
| 2002-12-31 | -0.70 |
| 2001-12-31 | -10.70 |
| 2000-12-31 | -6.20 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-02T19:05:52.185Z. Historical observations retain their original dates. Historical series through 2020-07-31.
